D.E. Shaw & Co
TRIL

D.E. Shaw & Co’s Trillium Therapeutics Inc. TRIL Stock Holding History

D.E. Shaw & Co’s Portfolio TRIL Stock Details TRIL Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
2021
Q3 		$597K Sell
2021
Q2 		$553K Buy
2021
Q1 		– Sell
2020
Q4 		$632K Sell
2020
Q3 		$741K Buy